Vitamin D for Muscle Strength & Physical Function

Skeletal muscle expresses the vitamin D receptor, and severe deficiency produces a recognisable clinical picture: proximal muscle weakness, difficulty rising from a chair or climbing stairs, and a waddling gait. That myopathy resolves with repletion, which is the firmest part of this pairing. The harder question is what supplementation does in people who are merely insufficient rather than deficient, and the answer from trials is: less than the mechanism suggests.

Pooled analyses in older adults generally show improvements in balance, postural sway and fall risk, with more equivocal findings for raw muscle strength. Trials in vitamin D-replete athletes have mostly shown nothing. There is also an inverted-U problem: very high intermittent doses have been associated with increased falls, so more is not better.

Calcitriol binding to the muscle vitamin D receptor drives genomic effects on myocyte proliferation and differentiation, upregulating myogenic regulatory factors and influencing type II fast-twitch fibre size — the fibres most involved in the rapid postural corrections that prevent a fall.

There is a faster, non-genomic component too: membrane-initiated signalling that modulates calcium influx and sarcoplasmic reticulum calcium handling, affecting excitation-contraction coupling directly. Vitamin D status also influences phosphate homeostasis, and hypophosphataemia independently impairs muscle ATP generation. Muscle vitamin D receptor expression declines with age, which is part of why older adults show the clearest functional response and younger replete athletes generally show none.

Daily moderate dosing is the right shape here. 800 to 2000 IU daily is the range associated with functional benefit in older adults, ideally guided by a 25(OH)D measurement; large annual or monthly boluses should be avoided given the fall-risk signal associated with them.

The published literature divides cleanly by baseline status. Meta-analyses in older and deficient populations report improvements in postural stability, time to complete functional tasks and fall incidence; trials in vitamin D-replete adults and athletes typically show no change in strength or power. Several high-dose bolus trials found more falls in the treatment arm, which is why dosing frequency has become part of the recommendation rather than an afterthought. No pair-specific studies are currently linked to this page, so no study list is displayed. Verified citations will be attached during editorial review rather than inferred here.

Vitamin D3 at maintenance doses is well tolerated. Toxicity requires sustained intake far above normal supplementation and presents as hypercalcaemia — nausea, thirst, confusion, kidney stones. The more relevant caution in this context is the paradoxical fall risk with very large intermittent doses.

Interactions fall into two groups: drugs that accelerate vitamin D breakdown and therefore raise your requirement, and drugs made more dangerous by a rise in serum calcium.